Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
4
TGA:4
Drug Approvals
CRYSVITA burosumab 20 mg/mL solution for injection in a 5 mL vial (340796)
- Product Name
- CRYSVITA burosumab 20 mg/mL solution for injection in a 5 mL vial
- Approval Date
- Sep 10, 2021
TGA
CRYSVITA burosumab 30 mg/mL solution for injection in a 5 mL vial (340797)
- Product Name
- CRYSVITA burosumab 30 mg/mL solution for injection in a 5 mL vial
- Approval Date
- Sep 10, 2021
TGA
CRYSVITA burosumab 10 mg/mL solution for injection in a 5 mL vial (340793)
- Product Name
- CRYSVITA burosumab 10 mg/mL solution for injection in a 5 mL vial
- Approval Date
- Sep 10, 2021
TGA
POTELIGEO mogamulizumab 4 mg/mL concentrate for solution for infusion (330232)
- Product Name
- POTELIGEO mogamulizumab 4 mg/mL concentrate for solution for infusion vial
- Approval Date
- Feb 5, 2021
TGA
Clinical Trials
No trials found
News
No news found